Slowly aligning regulatory and HTA for drugs
This article was originally published in SRA
Executive Summary
Seeking scientific advice from regulators early on in the new product development phase is becoming a way of life for many drug companies in the EU. The numbers are increasing year on year, figures from the European Medicines Agency show.